FDA clock ticking fast and new big buyers running out of time and may miss big move
Anything can happen at the FDA meeting on Oct 29, but the highest probability is that they will designate Ampion a "Breakthrough Treatment" simply because the actual trial data demonstrates that it really is.
Ampio lacks the endorsement of a big banker to spread all their good news but this will partially be offset with the FDA declaration of Ampion being a "Breakthrough Treatment".
If that happens, this good news won't need a big banker to get shares to explode because word will be delivered to the desk of every investor and institution on the planet . . . without a banker. Shares will soar because it will be a huge surprise and breakthrough to mainstream Wall Street.
The implications of Ampion are immense and far beyond the imagination of even the most bullish AMPE supporters.
An FDA designation of "Breakthrough Therapy" for Ampion is not certain, but it is obviously a very high probability.
Watch for shares to start running on big volume very soon as shorts and big buyers clash while they are driven by the 10/29 clock.
I agree, but the FDA decision may not come on Oct 29. It could take a few weeks. Please don't be disappointed If there is no decision on the 29th. In fact, the only decision you would probably get on the 29th is a denial. Approval will likely take a little longer.
If this actually regenerates cartilage in the knee and then elsewhere/hips -- then the company will be acquired once validated behind the scenes...At least with the $25MM, they have some bargaining table staying power. Would love to see it public and moved forward quickly...the bone on bone ski world could use a hit of this along with the standard Vitamin I*....